SHERRY BAKER: Open Payments
NPI 1225764285 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,110 in 166 payments from 18 companies in 2025. Trend: 2023 $76 · 2024 $317 · 2025 $3,110
Food & beverage: $2,941Education: $169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $620 |
| Regeneron Healthcare Solutions, Inc. | 15 | $485 |
| Galderma Laboratories, L.P. | 19 | $406 |
| GENZYME CORPORATION | 18 | $387 |
| UCB, Inc. | 39 | $365 |
| Amgen Inc. | 2 | $259 |
| LEO Pharma Inc. | 8 | $141 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, SKYRIZI, OTEZLA, RINVOQ, ANZUPGO, ADBRY.
Industry payments across LA — which companies pay providers there.
